SUBSCRIBE
SUBSCRIBE

Biogen

NEWS
Deals
Biogen Is Hunting For Neuroscience Deals Of All Sizes
July 26, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Job Trends
Biogen May Cut Jobs, Shutter Facilities to Streamline Ops and Free Up $400 Million for R&D
July 25, 2017
 · 
3 min read
How Biogen Makes Most of Its Cash
Genetown
How Biogen Makes Most of Its Cash
July 14, 2017
 · 
3 min read
Business
Big Expectations For Biogen’s New VP Of Governmental Affairs
July 12, 2017
 · 
1 min read
Drug Development
Why Biogen Spinoff Bioverativ’s Anemia Drug Could Be A Blockbuster
July 11, 2017
 · 
1 min read
Genetown
Liver Safety Issues Lead The EMA To Restrict Biogen’s MS Drug
July 10, 2017
 · 
1 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Deals
What Makes Biogen and Bristol-Myers Squibb Such Attractive Takeover Targets
June 27, 2017
 · 
3 min read
Genetown
Alzheimer’s Drug Leads UBS To Upgrade Biogen
June 21, 2017
 · 
1 min read
Investors Sigh With Relief as Biogen's Alzheimer's Drug Delivers in Early-Stage Study
Business
Biogen Brings Ex-Shire Exec Into C-Suite
June 20, 2017
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Drug Development
Biogen Idec, Inc. (Massachusetts) Says Death of MS Patient Not Related to Drug
October 8, 2013
 · 
1 min read
Business
Biogen Idec, Inc. (Massachusetts) to Report Third Quarter 2013 Financial Results on October 28, 2013
October 8, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts)'s Hot New MS Drug Tecfidera Maintains Efficacy in Long-Term Study
October 4, 2013
 · 
9 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity
October 3, 2013
 · 
1 min read
Drug Development
Biogen Idec, Inc. (Massachusetts) Release: New Data Analyses Show Significant Clinical and MRI Improvements With PLEGRIDY™ (Peginterferon Beta-1a)
October 1, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present Extensive New Data From Its Robust Multiple Sclerosis Portfolio at ECTRIMS
September 23, 2013
 · 
1 min read
Genetown
Biogen Idec, Inc. (Massachusetts) Employees Participate in Third Annual “Care Deeply Volunteer Day”
September 20, 2013
 · 
1 min read
Business
Amicus Therapeutics, Inc., Biogen Idec, Inc. (Massachusetts) to Team Up for Parkinson’s Disease
September 10, 2013
 · 
5 min read
Business
Biogen Idec, Inc. (Massachusetts) Makes $100 Million Upfront Payment in R&D Neurological Disorders Pact With Isis Pharmaceuticals, Inc.
September 9, 2013
 · 
7 min read
Genetown
Biogen Idec, Inc. (Massachusetts) to Present at the Stifel Nicolaus 2013 Global Healthcare Conference
September 4, 2013
 · 
1 min read
Load More